GlassScriptPhysician profile
William D Hudson
NPI 1578504734
$1,699.82
in general payments reported to CMS, 2019-2025
8 companies · $1,427 in 2025
The $1,427 reported for 2025 was more than what 75% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.44 · 2023: $39.59 · 2024: $199 · 2025: $1,427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,024 · Food and Beverage: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,024.25 |
| Food and Beverage | $641.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,389.48 | 2025 | Proclaim, Eterna |
| Abbvie INC. | $161.26 | 2023-2024 | |
| Vertex Pharmaceuticals Incorporated | $37.06 | 2024-2025 | |
| Ethicon US, LLC | $34.44 | 2021 | |
| Scilex Pharmaceuticals INC. | $23.04 | 2024 | |
| Collegium Pharmaceutical, INC. | $19.88 | 2024 | Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.97 | 2025 | Relistor |
| Stryker Corporation | $16.69 | 2024 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hudson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.